BRAIN Biotech AG, DE0005203947

BRAIN Biotech AG, DE0005203947

11.01.2022 - 18:53:33

BRAIN Biotech AG: BRAIN-Engineered-Cas Considered a Patentable Technology

11.01.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.dgap.de

Language: English Company: BRAIN Biotech AG Darmst?dter Stra?e 34-36 64673 Zwingenberg

Germany Phone: +49 (0) 62 51 / 9331-0 Fax: +49 (0) 62 51 / 9331-11 E-mail: ir@brain-biotech.com Internet: www.brain-biotech.com ISIN: DE0005203947 WKN: 520394 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1267548 ? End of News DGAP News Service

1267548??11.01.2022?

@ dgap.de